Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 12, 716-719, October 1, 1952]
© 1952 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miller, G. L.
Right arrow Articles by Eitelman, E. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miller, G. L.
Right arrow Articles by Eitelman, E. S.

An Electrophoretic Study on the Origin of the Abnormal Plasma Proteins in Multiple Myeloma*

Gail Lorenz Miller{dagger}, Clark E. Brown, Elizabeth Eshelman Miller and Edward S. Eitelman

(The Institute for Cancer Research, the Lankenau Hospital Research Institute, and the Lankenau Hospital, Philadelphia, Pa.)

An electrophoretic study has been made of the plasma and extracts of tumor of a typical multiple myeloma subject. Tumor tissue was obtained at autopsy from the vertebrae, ileum, and lymph nodes. Control tests were made with corresponding normal tissues and with tumor tissue from a patient with myelogenous leukemia. Vertebral marrow obtained from a multiple myeloma subject who had undergone treatment with urethan was also investigated.

A large, sharp peak characterizing the electrophoretic pattern of the plasma of the test subject also characterized the patterns of extracts of tumor-containing tissues of the same subject. This component was not observed in any of the control experiments. It was also absent in the extract of the marrow of the urethan-treated multiple myeloma subject, due, presumably, to the effect of the urethan in inhibiting or destroying the myeloma cells. The results appear to support the view that myeloma cells are the site of formation of the abnormal plasma proteins of multiple myeloma.

* This investigation was supported in part by a research grant from the National Cancer Institute, of the National Institutes of Health, Public Health Service, and in part by a grant from the American Cancer Society.

{dagger} Present address: Pioneering Research Laboratories, U.S. Army Quartermaster Corps, Philadelphia.

Received 6/ 5/52.


This article has been cited by other articles:


Home page
Arch Intern MedHome page
R. L. WALL
The Use of Serum Protein Electrophoresis in Clinical Medicine
Arch Intern Med, October 1, 1958; 102(4): 618 - 658.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1952 by the American Association for Cancer Research.